ABSTRACT: Crossbred pigs (n = 288; average age = 21 ± 3 d and BW = 7.1 ± 0.2 kg) were used in a 42-d trial to determine the infl uence of a microbial phytase and various doses of ZnO on growth performance and serum minerals. Pigs (6 castrated males or females/pen) were randomly allotted to treatments in a 2 × 3 factorial arrangement with 2 dietary levels of a microbial phytase (0 or 2,500 phytase units/kg) and 3 dietary levels of supplemental ZnO [0, 1750, or 3,500 mg/kg ZnO (72% Zn)] with 4 pens of castrated males and 4 pens of females per treatment. Diets were formulated to exceed all nutrient requirements, including Ca and P from d 0 to 21 (phase 1) and d 22 to 42 (phase 2). Growth performance, serum Zn, and serum P were not infl uenced (P > 0.05) by a ZnO × phytase interaction during phase 1, phase 2, or overall (d 0 to 42). Phytase increased (P = 0.01) ADFI and improved (P = 0.02) ADG in phase 1 and improved (P = 0.01) overall ADG, regardless of the level of ZnO supplemented. Zinc oxide supplementation linearly reduced (P = 0.05) ADG, and ZnO at 3,500 mg/kg reduced (quadratic, P = 0.04) G:F in pigs (phase 2). During phase 1, phytase increased serum Ca, but only in the absence of ZnO supplementation, which resulted in a ZnO × phytase interaction (P = 0.02). Serum Zn was increased (linear, P < 0.001) and serum P was decreased (linear, P = 0.05) as ZnO supplementation increased in the diet (phase 1). In phase 2, serum Ca was reduced (linear, P = 0.04) and serum Zn was increased (linear, P = 0.02) as ZnO supplementation increased in the diet. Phytase supplementation increased (P = 0.009) serum Zn and increased (P = 0.003) serum P (phase 1). There was no infl uence of phytase supplementation on serum minerals in phase 2. In summary, supplemental ZnO reduced growth performance in this experiment. Phytase supplementation improved ADG in Ca-and P-adequate diets regardless of the level of ZnO supplemented, which may be attributed to the reduction of phytate as an antinutrient. In addition, through phytate hydrolysis, phytase reduced phytate-Zn interactions and increased serum Zn, Ca, and P. However, supplementing ZnO increased serum Zn, which reduced serum P and Ca, indicating Ca-Zn-P precipitation. In addition, phytase increased serum Ca, but only in the absence of Zn, further indicating a complex interaction between Zn, Ca, and P in the blood.
INTRODUCTION
Microbial phytase effi cacy was reduced approximately 30% when dietary ZnO or ZnCl was supplemented at 1,500 mg/kg in corn-soybean meal-based pig diets (Augspurger et al., 2004) . The authors postulated that Zn exerts its effect on P availability and phytase efficacy through binding with the phytate molecule and preventing access for phytase hydrolysis. Phytate is a strong chelator of divalent cations, with a preferential binding capacity for Zn, especially at a Zn:phytate molar ratio of 4:1 at pH 7.0 (Champagne et al., 1990) . Zinc oxide is commonly fed at pharmacological doses (2,000 to 3,500 mg/kg) in weanling pig diets as a growth promoter and to prevent postweaning diarrhea (Carlson et al., 1999) . However, Hill et al. (2001) reported a quadratic effect of ZnO supplementation on ADG and G:F, and nursery pigs fed 3,000 mg/kg supplemental ZnO were 8% lighter and 5% less effi cient compared with nursery pigs fed 2,000 mg/kg supplemental ZnO.
Depending on the percentage of plant-based feed ingredients, newly weaned pig diets may contain between 6 and 15 mmol of phytate. Assuming an average of 40 mmol of Zn, in the presence of pharmacological levels of ZnO (2,000 to 3,500 mg/kg), weaned pig diets may contain a Zn:phytate molar ratio of 4:1, which is favorable for Znphytate precipitation (Champagne et al., 1990) . Microbial phytase is effi cacious at hydrolyzing phytate and improved ADG, G:F, and P digestibility in pigs fed reduced available P diets (Jendza et al., 2005) and increased plasma Zn in piglets fed recommended levels of Zn (Revy et al., 2006) . In addition, Revy et al. (2006) determined the Zn requirement of weaned pigs may be reduced in the presence of microbial phytase. This indicates that pharmacological levels of dietary Zn may also be reduced in young pig diets in the presence of microbial phytase.
Decreasing the level of pharmacological Zn may reduce the Zn to phytate molar ratio and mitigate the precipitation of Zn and phytate and thereby improve the effi cacy of phytase. The objectives of this experiment were to determine if the effect of supplemental ZnO interacted with a high dose of a microbial phytase in P-and Caadequate diets and if the presence of phytase allows for a reduced dosage of ZnO to achieve the same end result on pig growth performance and serum minerals.
MATERIALS AND METHODS
The trial was conducted at a commercial facility in collaboration with the Bangkok Animal Research Center in Thailand under the guidelines of the ethical principles for use of animals for scientifi c purposes according to the National Research Council of Thailand.
Two hundred eighty-eight crossbred (Landrace × Large White × Duroc) weaned pigs (21 ± 3 d postfarrowing) were sorted by BW and randomly allotted to 6 dietary treatments in a 42-d experiment. Dietary treatments were replicated using 8 pens of 6 pigs of the same sex in each pen (4 pens of castrated males and 4 pens of females). The average initial BW of each pen was 7.1 ± 0.2 kg. Dietary treatments were arranged as a 2 × 3 factorial, which included 2 levels of a novel microbial 6-phytase [0 or 2,500 phytase units (FTU)/kg] and 3 levels of supplemental ZnO (0, 1,750, or 3,500 mg/kg). The phytase used was derived from an Escherichia coli 6-phytase expressed in Trichoderma reesei and contained a declared activity of 5,000 FTU/g (Quantum Blue, AB Vista Feed Ingredients, Marlborough, UK). Phytase activity in the feed was analyzed according to modifi ed methods of Engelen et al. (2001) ; 1 FTU is defi ned as the amount of enzyme required to release 1 mol of inorganic P/min from rice bran phytate at pH 4.5 and 60°C. Diets were fed in 2 feeding phases from d 0 to 21 (phase 1) and d 22 to 42 (phase 2). The ingredient composition and the calculated and analyzed nutrient inclusion levels of the experimental diets for phases 1 and 2 are presented in Tables 1 and 2 , respectively. All diets were fed in meal form and formulated to meet or exceed NRC (1998) requirements for 5 to 10 kg (phase 1) and 10 to 20 kg (phase 2) pigs. All pigs were housed in an opensided barn with continuous lighting. Each pen contained 2 nipple drinkers and gutter feeders to facilitate ad libitum access to water and feed. Pig BW and feed disappearance were measured at the beginning of the experiment (d 0), at the end of phase 1 (d 21), and at the end of the experiment (d 42) to calculate ADG, ADFI, and G:F.
Blood samples were collected from 2 pigs/pen via jugular venipuncture on d 21 and 42. Samples (approximately 6 mL/tube) were collected into plastic tubes containing no anticoagulant. Blood was allowed to clot at room temperature and was centrifuged at 1,155 × g for 5 min at room temperature, and serum was separated and stored at −20°C until further analysis. Serum Ca was determined (AU400; Beckman Coulter, Nyon, Switzerland) according to Ca arsenazo III methods (Palade and Vergara, 1983) and phosphomolybdate methods (AOAC, 1970) for P (7.095 to 7.098). Serum Zn was determined by atomic absorption spectrophotometry (AAnalyst 800, PerkinElmer, Inc., Shelton, CT).
All data were analyzed as a completely random design using the fi t model platform (JMP 9.0; SAS Inst. Inc., Cary, NC). Orthogonal contrasts appropriate for a 2 × 3 factorial arrangement of treatments were used to determine linear and quadratic effects of ZnO supplementation, the main effect of phytase supplementation, and phytase × ZnO interactions. Where interactions were deemed signifi cant, the simple means were separated using a t test. The pen served as the experimental unit for all data. Signifi cance was accepted at P < 0.05.
RESULTS
The analyzed values of Ca, P, and Zn in the diets were fairly close to calculated values (Tables 1 and 2 ). The diets that were not supplemented with phytase contained fewer than 60 FTU/kg (phases 1 and 2), and the phytase-supplemented diets contained approximately 2,760 FTU/kg (phase 1) or 2,650 FTU/kg (phase 2) by analysis (Tables 1 and 2) .
Phytase supplementation at 2,500 FTU/kg increased (P = 0.01) ADFI and improved (P = 0.02) ADG of pigs in phase 1 and improved (P = 0.01) overall ADG (Table 3 ). In phase 1 or overall (d 0 to 42), there was no infl uence of ZnO supplementation on ADFI, ADG, or G:F. However, in phase 2, ADG was linearly reduced (P = 0.05) as ZnO supplementation increased from 0 to 3,500 mg/kg, and 1 Three additional diets, identical to the 3 basal diets above, were formulated to contain phytase at the expense of corn at 0.05%. This level of phytase was equivalent to 2,500 U/kg of the diet, and recoveries were 2,770, 2,570, and 2,940 U/kg, respectively. The phytase used was Quantum Blue (AB Vista Feed Ingredients, Marlborough, UK) and had an expected activity of 5,000 U/g. 1 Three additional diets, identical to the 3 basal diets above, were formulated to contain phytase at the expense of corn at 0.05%. This level of phytase was equivalent to 2,500 U/kg of the diet and recoveries were 2,550, 2,600, and 2,790 U/kg, respectively. The phytase used was Quantum Blue (AB Vista Feed Ingredients, Marlborough, UK) and had an expected activity of 5,000 U/g. G:F was greatest in pigs fed 1,750 mg/kg ZnO, which resulted in a quadratic (P = 0.04) effect of ZnO on G:F. In phase 1, phytase supplementation increased (P = 0.02) serum Ca, but only in the absence of ZnO supplementation, which resulted in a phytase × ZnO interaction (P = 0.02; Table 4 ). In phase 1, phytase supplementation at 2,500 FTU/kg increased serum P (P = 0.003) and serum Zn (P = 0.009). Zinc oxide supplementation reduced (linear, P = 0.05) serum P (phase 1) and increased (linear, P < 0.001) serum Zn. In phase 2, ZnO supplementation reduced (linear, P = 0.04) serum Ca and increased (linear, P = 0.02) serum Zn. Phytase did not infl uence serum minerals in phase 2.
DISCUSSION
Phytase improved ADG regardless of the level of ZnO supplemented, as indicated by the lack of a phytase × ZnO interaction. Experimental diets were formulated to contain adequate levels of P. Improvements in pig growth performance have been reported as a result of phytase supplementation to diets adequate in P (Adeola et al., 1995) . However, Martinez et al. (2005) reported no improvements in ADG of newly weaned pigs fed pharmacological Zn and phytase. The reported improvements in ADG may be associated with the hydrolysis of phytate by phytase. Phytate is an antinutrient and has been implicated in reducing Ca, Mg, P, Na, and K digestibility in pigs (Woyengo et al., 2009 ). Through complex interactions within the gastrointestinal tract, phytate reduced pepsin and trypsin activity in broilers (Liu et al., 2009) , bound cofactors such as Zn and Ca (Champagne and Phillippy, 1989) , which are used to activate endogenous enzymes, increased endogenous secretions of protein and mucin in broilers (Onyango et al., 2009) , reduced apparent energy metabolism by approximately 8% (Liao et al., 2005) , and reduced BW gain and feed effi ciency in pigs (Woyengo , 2012) . In addition, phytate reduced AA digestibility by 1% to 7%, depending on the AA determined (Liao et al., 2005) . Therefore, the net effect of phytate in growing pig diets encompasses more than P nutrition, and high dietary phytase supplementation may improve ADG in P-adequate diets through the nearly complete hydrolysis of phytate (Shirley and Edwards, 2003) and alleviation of the antinutrient effects of phytate.
In the current trial, serum P and Zn were increased with phytase supplementation at d 21, which agrees with previous results (Revy et al., 2006) . This effect is likely a result of hydrolysis of phytate. However, the phytase effect on serum Ca was negated in pigs fed diets supplemented with ZnO, serum P was linearly reduced in 21-dold pigs, and growth performance was reduced in phase 2 as ZnO supplementation increased, which led to an overall 5% reduction in ADG when ZnO was supplemented at levels greater than 1,750 mg/kg; this was true for both the non-phytate-and phytase-supplemented diets. The linear reduction in ADG with increasing Zn supplementation was most likely due to a marginal Zn toxicity as Zn accumulates in the tissues. For example, during the fi rst 11 d of pharmacological Zn supplementation, Zn was stored in pig tissues and excess Zn excretion occurred only after 14 d (Martinez et al., 2005) . Therefore, feeding pharmacological Zn approximately 3 wk postweaning may be detrimental to pig growth performance.
Serum minerals may be used as an indicator of mineral status of the animal and increasing Zn supplementation increased serum Zn, which is in agreement with previous reports (Carlson et al., 1999; Martinez et al., 2005; Rincker et al., 2005) . However, the reduction in serum P concentration that was observed in the present experiment as a result of increased dietary Zn, contradicts results reported by Martinez et al. (2005) and Shelton et al. (2011) . The adequate level of P in the diet and the use of phytase at rates above commercial recommendations may explain the differences between the serum P and Zn found in this trial compared with published reports. The antagonistic nature of Zn and P is well known in soils and plants (Zhu et al., 2001; Gill et al., 2004) . Yang et al. (2011) determined that excess Zn decreased P uptake from the soil by approximately 23% and subsequently reduced the phytate concentration in the wheat grain. Additionally, the uptake of Zn into the stems and leaves of corn or wheat was negatively correlated with the levels of P in the soil at pH 5.1 or 7.2 (Khan and Zende, 1977) . However, the relationship between Zn and phosphate and their absorption in the small intestine is less well known in pigs. Although not tested in the current trial, at conditions within the small intestine, Zn and phosphate may have precipitated, which may have resulted in reduced serum P as ZnO supplementation increased. The relationship between Zn and phosphate is particularly interesting when evaluating phytase effi cacy in reduced P diets and in the presence of pharmacological levels of ZnO, as commonly found in weaned pig diets. Augspurger et al. (2004) reported that the effi cacy of phytase was reduced approximately 30% in low total P diets in the presence of pharmacological levels of ZnO. The basal diet contained approximately 0.32% total P, and therefore, the precipitation of Zn with phosphate in the gastrointestinal tract may have masked the effect of phytase.
However, it is more likely the infl uence of Zn on P in the current trial was the result of Zn-phytate interactions. Phytate preferentially precipitates with Zn, creating an insoluble complex at a Zn:phytate molar ratio of 4:1 (Champagne et al., 1990) and may reduce phytase effi cacy through promoting Zn-phytate complexes, which are inaccessible to phytase (Maenz et al., 1999) . In the current study, phytase supplementation above commercial rates improved ADG and G:F, especially when ZnO was supplemented at 1,750 mg/kg. However, ADG was numerically reduced when ZnO supplementation increased to 3,500 mg/kg. Using published data on the phytate content in grains (Nelson et al., 1968; Gualberto et al., 1997; Lott et al., 2000) and inclusion levels, the dietary phytate concentration in the current trial was estimated at 0.79% (11.9 mmol phytate). When pigs were fed 1,750 mg/kg (26.9 mmol Zn), the molar ratio was 2.3:1, possibly too low to cause precipitation, but at 3,500 mg/kg (53.9 mmol Zn) ZnO the Zn:phytate molar ratio was 4.5:1, which likely promoted Zn:phytate precipitation and reduced phytase effi cacy in the high-Zn diets.
The growth performance data, especially the serum data, indicate a complex interaction between phytate, Zn, P, and phytase. Supplementation of diets with pharmacological ZnO had no benefi cial effects on ADG in the current trial, which agrees with previous data (Martinez et al., 2005) and may be the result of the presence of antibiotics in the pig diets. In contrast, pharmacological Zn improved ADG (Carlson et al., 1999; Hill et al., 2001) , reduced E. coli K88 growth in vitro (Molist et al., 2011) , increased tissue metallothione concentration (Carlson et al., 1999; Martinez et al., 2005) in weaned pigs, and may have growth promoting benefi ts that are not fully understood. Additionally, through the elimination of the antinutrient properties of phytate, phytase improved young pig growth performance in P-adequate diets. Further understanding of the P, Zn, and phytate interactions within the pig gastrointestinal tract will facilitate diet formulation in the presence of phytase and pharmacological Zn.
Results of the current experiment indicate that interactions among Zn, P, and phytate exist and that there are possible benefi ts associated with reduced ZnO to avoid a Zn:phytate ratio approaching 4:1. At a Zn:phytate ratio above 4:1, the benefi ts of both phytase and ZnO may be severely diminished, and in fact, the net result may be detrimental. Results of this experiment also indicate an antagonistic relationship between Zn and P in the gastrointestinal tract, which reduced serum P and may mask the P-releasing values of phytase. In addition, the use of high doses of phytase with moderate pharmacological dosages of Zn can result in plasma Zn levels approaching that observed with much greater levels of Zn in the absence of phytase. If this is an indicator of available Zn and if availability of Zn is required for its growth-promotant-like effects, then it indicates that the levels of supplemental Zn needed to elicit a benefi cial effect may be reduced in the presence of phytase above current rates. Further work using microbially challenged growing pigs and various phytase doses is needed to validate this concept.
